Monetary Management Group Inc
Source: SEC Form 13F · as of Mar 2026Monetary Management Group Inc holds 18 biotech & pharma companies tracked by BioSniper, totaling $43.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$43.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 15,650 | $14.4M |
| ABBVAbbVie Inc. | 34,230 | $7.4M |
| AMGNAMGEN INC | 13,296 | $4.7M |
| JNJJOHNSON & JOHNSON | 16,595 | $4.1M |
| PMPhilip Morris International Inc | 16,620 | $2.7M |
| ABTABBOTT LABORATORIES | 21,897 | $2.2M |
| MRKMerck & Co., Inc. | 15,985 | $1.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,083 | $1.9M |
| PFEPFIZER INC | 36,700 | $1.0M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 14,660 | $809K |
| BMYBRISTOL MYERS SQUIBB CO | 12,850 | $779K |
| REGNREGENERON PHARMACEUTICALS, INC. | 712 | $550K |
| AZNASTRAZENECA PLC | 2,750 | $542K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 565 | $252K |
| NVSNovartis AG | 1,259 | $192K |
| MCKMcKesson Corporation | 100 | $87K |
| ELVElevance Health Inc. | 250 | $73K |
| GILDGILEAD SCIENCES, INC. | 250 | $35K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.